O n March 28, 2011, the AOAC Board of Directors approved an alternative path to achieve Offi cial First Action status. Following this process, selected methods are reviewed and approved by an Expert Review Panel (ERP) for AOAC Offi cial First Action status. Methods selected through this process remain First Action for a period of approximately 2 years. This allows time for the methods to be used in laboratories and to generate additional information. ERPs will monitor the methods' performance, and after about 2 years, the ERP will decide if the methods are suitable for recommendation to the Offi cial Methods Board for Final Action (1) .
The approved HPLC method for vitamin B 12 utilizes solidphase extraction to concentrate and clean up sample extracts, size-exclusion and reversed-phase chromatography to separate vitamin B 12 from interfering compounds, and visible detection at 550 nm to measure vitamin B 12 concentrations. Vitamin B 12 is extracted from infant and adult nutritional products with a sodium acetate buffer (pH 4.5) and potassium cyanide at 105°C. Product extracts are fi ltered, and a portion of the fi ltrates is loaded onto preconditioned C8 or C18 SPE cartridges. Vitamin B 12 is eluted from the SPE cartridges into 5 or 10 mL volumetric fl asks with 25-30% acetonitrile in water. When samples are eluted into 5 mL volumetric fl asks, a dilute cyanide solution is added to the volumetric fl asks and the fl asks are heated at 95°C to evaporate most of the acetonitrile. After acetonitrile has evaporated, samples are diluted to 5 mL with water. Samples eluted into 10 mL volumetric fl asks are immediately diluted to volume with water. A 2 mL amount of prepared product sample is injected onto a size-exclusion column, where vitamin B 12 is eluted with 2.5% acetonitrile in water. As vitamin B 12 elutes from the size-exclusion column, a column switch takes place, and vitamin B 12 is loaded onto a 3 μm, 100 × 4.6 mm, C18 column where B 12 is further separated from interfering compounds and eluted with an acetonitrile and water gradient. As vitamin B 12 elutes from the C18 column, it is detected by using visible light at 550 nm, and the concentration of vitamin B 12 in products and premixes is calculated by comparison of the areas of samples to the areas of standards of known concentration. See Table 2011 .10A for infant formula and adult nutritional matrixes for which the method was validated.
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A. Principle
Vitamin B 12 is extracted from the sample using sodium acetate buffer (pH 4.5) and potassium cyanide at 105°C. Extracts are purifi ed and concentrated with C8 or C18 solid-phase extraction (SPE) cartridges and analyzed with size-exclusion and reversedphase chromatography. Determination of B 12 is made by liquid chromatography with visible detection at 550 nm.
B. Apparatus and Materials
(a) HPLC system.-Gradient system with switching valve and isocratic pump on side and a UV-Vis detector equipped with a tungsten lamp (capable of monitoring at 550 nm wavelength). Autosampler capable of injecting 2 mL sample.
(b) Column.-Analytical size-exclusion column 4 μ, 250 × 9.4 mm (Zorbax GF-250, P/N 884973-901; www.chem. agilent.com), 5 μ, 300 × 8 mm (Shodex Protein KW-802.5, P/N F6989000) or equivalent.
(c) Column.-Analytical C 18 column 3 μ, 100 × 4.6 mm (Thermo Scientifi c Aquasi1 P/N 77503-104630; www. thermoscientifi c.com) with C 18 drop-in guard cartridges 3 μ, 10 × 4.6 mm (Thermo Scientifi c Aquasil P/N 77503-014001) or equivalent.
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D. Solution and Standard Preparation
All solutions can be scaled up or down for convenience provided good laboratory practices are observed. Solutions can be stored at 2-30°C in tight, inert containers unless otherwise noted.
(a) Solutions.-(1) Mobile phase A.-4.0 mL TEA diluted with 1000 mL water and adjust pH to 5-7 with concentrated formic acid.
(2) Mobile phase B.-4.0 mL TEA and 250 mL acetonitrile diluted with 750 mL laboratory water and adjust pH to 5-7 with concentrated formic acid.
(3) Mobile phase C.-4.0 mL TEA and 750 mL acetonitrile diluted with 250 mL laboratory water and adjust pH to 5-7 with concentrated formic acid. 
E. Procedure
Prepare all samples under UV shielded fl uorescent lights. Store prepared product samples up to 14 days after preparation (store at 2-8°C in tightly stoppered volumetric fl asks). Mix or stir products before sampling to ensure all product samples are uniform and representative.
(a) Sample preparation for infant and adult nutritional products.
- (1) Sampling.-Mix all products thoroughly before sampling. Reconstitute nonhomogeneous powders per label instructions. Weigh the appropriate amount of sample (±10%) into a 100 mL volumetric fl ask and record the weight to at least 4 signifi cant fi gures. Typical weights are 20-30 g for readyto-feed (RTF) liquids and reconstituted powders and 3 g for unreconstituted powders. Add 25 mL laboratory water to all unreconstituted powder samples and mix until all of the powder dissolves.
Add 1 mL of 6% taka-diastase if samples contain signifi cant levels of starch. Allow taka-diastase to react with samples for at least 30 min before continuing with the extraction.
(2) Extraction.-Add 30 mL 0.1 M sodium acetate buffer (pH 4.5) to each sample and swirl to mix.
In a hood, add 1 mL freshly prepared 1% KCN to each sample and swirl to mix.
Heat samples in a 105°C oven for at least 60 min, but for no more than 120 min. (Oven temperature will drop when the door is opened. Start timing when oven temperature returns to 105°C.)
After at least 60 min, remove samples from oven and immediately cool in ice bath.
Dilute samples to volume with laboratory water. Mix well. Filter samples through Whatman 2V fi lter paper (www. whatman.com) into 125 mL Erlenmeyer fl asks or equivalent glassware. Note: If prepared samples are milky and contain very small insoluble particles, centrifuge samples and transfer liquid layer to funnels lined with fi lter paper.
(3) Sample concentration.-For each sample that will be cleaned up and concentrated, insert a 600-900 mg SPE cartridge onto the stopcock of the vacuum manifold and attach a 30 mL disposable syringe barrel to the top of each cartridge. As a general guideline, 600 mg Alltech C 8 or C 18 cartridges have enough capacity for use with most products; however, if products on an RTF basis contain high levels of protein (>5-6%) or high levels of hydrolyzed proteins (>4%), 900 mg Alltech C 8 or C 18 cartridges should be used. Note: Alltech C 8 and C 18 cartridges can be used interchangeably.
Condition each cartridge with at least 20 mL acetonitrile and rinse each cartridge with at least 10 mL laboratory water.
Using volumetric pipets, transfer sample fi ltrates to cartridges using the guidelines in Table 2011 .10B. If necessary apply enough vacuum so that the samples drip steadily through the cartridges. Discard eluant.
After all of the sample fi ltrate has passed through the cartridge, rinse each cartridge with 5 mL laboratory water and discard eluant. Air-dry each cartridge by pulling a vacuum until no more effl uent is observed. Close each stopcock.
Place a 5 or 10 mL volumetric fl ask under each cartridge. Add 4.4 mL 25% acetonitrile to all Alltech 600 mg cartridges and 4.4 mL 30% acetonitrile to all Alltech 900 mg cartridges. Open each stopcock and elute vitamin B 12 into the volumetric fl asks.
Final dilution.-For samples collected in 10 mL volumetric fl asks, dilute to volume with water. For samples collected in 5 mL volumetric fl asks, in a hood add 0.1 mL freshly prepared 0.4% KCN to each volumetric fl ask. Place prepared samples in a 95°C oven for at least 1.5 h, but for no more than 4 h. After at least 1.5 h, remove samples from the oven and cool to room temperature. Dilute to volume with laboratory water. If the system is working properly, inject a set of 3-6 working standards once, followed by a control sample, a set of 1-14 samples, and another set of 3-6 working standards. Every set of 1-14 samples should be bracketed by standards of appropriate concentration. At each standard concentration, average the peak area of the standard injected at the beginning of a set of samples with the peak area of the standard injected at the end of the set of samples. Prepare a standard curve by performing linear least squares (regression) on concentration versus the average peak areas of the working standards. A standard curve must have a correlation of at least 0.999 to be considered acceptable for sample calculations.
(2) At each working standard concentration, the peak areas of standards injected at the beginning and end of a set of samples should not increase or decrease by more than 10%. where C p = product concentration in g/kg; C i = vitamin B 12 concentration of the injected sample preparation extrapolated from standard curve in g/L; D 1 = volume of the fi rst dilution in mL (100 mL); ss = sample size in g; D 2 = volume of the second (fi nal) dilution in mL; V = volume of fi ltrate loaded onto the cartridge in mL.
For each set of samples, the control result must be within 3 standard deviations of the control mean. 
